Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lung Neoplasms × Calcium Dobesilate × Clear all

Phase

Phase 2 2 Phase 1/2 2 Phase NA 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Nausea 3 Vomiting 2 Multiple Myeloma 2 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain, Postoperative 1 Pain 1 Neuralgia 1 Lung Neoplasms 1 Leukemia, Biphenotypic, Acute 1 Intestinal Diseases 1 Inflammatory Bowel Diseases 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Digestive System Diseases 1 Crohn Disease 1 Colorectal Neoplasms 1

Interventions

Propofol 5 Sevoflurane 3 Saline Solution 3 Erlotinib Hydrochloride 3 Carboplatin 3 Acetaminophen 3 Nivolumab 2 Midazolam 2 Lidocaine 2 Docetaxel 2 Cryotherapy 2 Bupivacaine 2 Bronchoscopy 2 Anesthesia, Inhalation 2 trametinib 1 sotorasib 1 pegfilgrastim 1 icotinib 1 endostar protein 1 durvalumab 1 dabrafenib 1 capmatinib 1 camrelizumab 1 beta Carotene 1 atezolizumab 1 Zoledronic Acid 1 Vitamin A 1 Tobacco Use Cessation Devices 1 Sunitinib 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02275702 2021-08-25

APV

Laval University

Phase 4 Completed

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡